JAMA Network Home
Sign In
Editor's Pick JAMA Insights

Cannabinoid Hyperemesis Syndrome

JAMA 10.1001/jama.2026.7873

August 26, 2026 at 11:00 AM EDT

Read the full article

This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.

Corresponding Author: Michael Camilleri, MD, DSc, Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic Minnesota, 200 First St SW, Charlton Bldg, Room 8-110, Rochester, MN 55905 (camilleri.michael@mayo.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.7873?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082626

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks